文献速递心力衰竭与心肌病

机器学习亚表型揭示射血分数保留型急性心衰的病理生理机制

Pathophysiological insights into machine learning-based subphenotypes of acute heart failure with preserved ejection fraction.
PubMed 文献 · Heart · 2024-02-23

本研究基于PURSUIT-HFpEF研究(N=1231)中的亚队列(N=212),应用机器学习聚类模型将急性失代偿性HFpEF分为四种表型,并评估各表型生物标志物差异。结果发现表型1的NT-proBNP、hs-CRP、TNF-α、GDF-15、肌钙蛋白T和胱抑素C最低,而伴有高血压和心脏肥厚的表型2上述标志物最高,提示不同表型存在差异化病理生理机制,炎症对经典心脏肥厚型HFpEF贡献显著。

要点

  • 机器学习可识别HFpEF四种亚表型,生物标志物谱存在显著差异。
  • 表型2(高血压+心脏肥厚)炎症标志物最高,提示炎症驱动。
  • 表型1生物标志物普遍最低,表型4 NT-proBNP低但GDF-15较高。

核心结论

  • HFpEF不同表型的生物标志物特征差异反映其 underlying 机制不同。
  • 系统性炎症在经典心脏肥厚型HFpEF的病理生理中起重要作用。

研究设计与样本

  • 回顾性分析PURSUIT-HFpEF研究(N=1231)中的多生物标志物亚队列(N=212)。
  • 应用先前建立的机器学习聚类模型将亚队列分为四种表型:表型1(n=69)、表型2(n=49)、表型3(n=41)、表型4(n=53)。

主要发现

  • 表型1的NT-proBNP、hs-CRP、TNF-α、GDF-15、肌钙蛋白T和胱抑素C水平最低。
  • 表型2(以高血压和心脏肥厚为特征)上述标志物水平最高。
  • 表型3的GDF-15和胱抑素C水平第二高。
  • 表型4的NT-proBNP水平低而GDF-15相对较高。

临床怎么用

  • 临床可依据生物标志物谱区分HFpEF亚表型,辅助个体化机制导向治疗。
  • 对高血压伴心脏肥厚表型应关注炎症通路干预。

局限性

  • 回顾性分析,样本量有限(亚队列N=212)。
  • 为观察性研究,不能确立因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The heterogeneous pathophysiology of the diverse heart failure with preserved ejection fraction (HFpEF) phenotypes needs to be examined. We aim to assess differences in the biomarkers among the phenotypes of HFpEF and investigate its multifactorial pathophysiology. METHODS: This study is a retrospective analysis of the PURSUIT-HFpEF Study (N=1231), an ongoing, prospective, multicentre observational study of acute decompensated HFpEF. In this registry, there is a predefined subcohort in which we perform multibiomarker tests (N=212). We applied the previously established machine learning-based clustering model to the subcohort with biomarker measurements to classify them into four phenotypes: phenotype 1 (n=69), phenotype 2 (n=49), phenotype 3 (n=41) and phenotype 4 (n=53). Biomarker characteristics in each phenotype were evaluated. RESULTS: Phenotype 1 presented the lowest value of N-terminal pro-brain natriuretic peptide (NT-proBNP), high-sensitive C reactive protein, tumour necrosis factor-α, growth differentiation factor (GDF)-15, troponin T and cystatin C, whereas phenotype 2, which is characterised by hypertension and cardiac hypertrophy, showed the highest value of these markers. Phenotype 3 showed the second highest value of GDF-15 and cystatin C. Phenotype 4 presented a low NT-proBNP value and a relatively high GDF-15. CONCLUSIONS: Distinctive characteristics of biomarkers in HFpEF phenotypes would indicate differential underlying mechanisms to be elucidated. The contribution of inflammation to the pathogenesis varied considerably among different HFpEF phenotypes. Systemic inflammation substantially contributes to the pathophysiology of the classic HFpEF phenotype with cardiac hypertrophy. TRIAL REGISTRATION NUMBER: UMIN-CTR ID: UMIN000021831.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Sotomi, Tamaki, Hikoso, et al. Pathophysiological insights into machine learning-based subphenotypes of acute heart failure with preserved ejection fraction. Heart. 2024. PMID: 37827559. doi:10.1136/heartjnl-2023-323059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。